Loading…
Radioiodination of 1-(2-deoxy- β- d-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studies
Iodine-124 was produced via the 124Te(p,n) 124I reaction by 15 MeV proton irradiation of an in-house solid mass tellurium dioxide target, using the Tübingen PETtrace TM (General Electric Medical Systems) cyclotron. 1-(2-Deoxy- β- d-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a stable, non-pol...
Saved in:
Published in: | Applied radiation and isotopes 2008-09, Vol.66 (9), p.1221-1228 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Iodine-124 was produced via the
124Te(p,n)
124I reaction by 15
MeV proton irradiation of an in-house solid mass tellurium dioxide target, using the Tübingen PETtrace
TM (General Electric Medical Systems) cyclotron. 1-(2-Deoxy-
β-
d-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a stable, non-polar thymidine mimic nucleoside, was synthesized in 5 steps following a literature method, for radioiodination with [
124I] iodide via isotope exchange in the presence of copper sulphate and ammonium sulphate in methanol-water. The radiolabelling procedure was optimized with respect to temperature, amount of dRFIB, amount of sodium hydroxide and reaction time, to produce radiochemical yields of up to 85% with a 1-h reaction at 140
°C. With routine I-124 production of 30
MBq/run, relatively high specific activities, approaching 100
MBq/mmol, can be expected. The activation energy for dRFIB radioiodination was calculated from temperature-time RCY data to be approximately 100
kJ/mol using no-carrier-added [
124I]iodide. |
---|---|
ISSN: | 0969-8043 1872-9800 |
DOI: | 10.1016/j.apradiso.2008.01.014 |